TAPI

We’re heading to Basel this November for TIDES: Oligonucleotides and Peptide Therapeutics Europe 2025! From complex GLP-1 peptides to cutting-edge oligonucleotide development, TAPI’s integrated expertise and infrastructure are built to accelerate your programs.   Meet our experts at booth 338 to explore how we can help you overcome R&D challenges, scale with confidence, and secure long-term success. Book your meeting through the event platform today.

Just one week to go until the pharma industry gathers at CPHI Worldwide 2025 in Frankfurt! Visit us at the Frankfurt Messe, Hall 6.1 | Booth A32, where our representatives from Commercial, Manufacturing, R&D, CDMO, Product, and Procurement will be available. We look forward to connecting with colleagues, customers, and partners to exchange insights and explore opportunities that drive progress across the industry.

The countdown is on until World ADC Event Series #WorldADCSanDiego2025! TAPI is proud to be a trusted partner in advancing the #ADC field. With nearly 90 years of expertise and specialized #CDMO capabilities, we’re one of the few CDMOs already supporting partners with payloads and linkers used in commercial ADCs. Our R&D experts and CDMO leads will be on-site at Booth 63 to discuss how our High Potent APIs (OEB6) and tailored solutions can support your ADC projects from development through commercialization. Let’s explore how we can collaborate to maximize therapeutic success. 

🎉 𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐗 𝐃𝐚𝐲 𝟐𝟎𝟐𝟓 – 𝐂𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐢𝐧𝐠 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫𝐬, 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐏𝐫𝐨𝐠𝐫𝐞𝐬𝐬 🎉   Today we are celebrating Global CX Day 2025, a moment to recognize the vital role our customers play in everything we do at 𝐓𝐀𝐏𝐈. Their trust motivates us, their challenges drive us to improve, and their successes give meaning to our work. Working toward meaningful goals gives us a deep sense of pride and responsibility. We also take this opportunity to acknowledge our dedicated CX #teams, whose commitment ensures the customer voice remains at the heart of every decision, turning feedback into action and action into progress. Together, we’re building stronger partnerships, delivering innovative solutions, and creating shared value for the future. 𝐇𝐚𝐩𝐩𝐲 𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐗 𝐃𝐚𝐲 𝟐𝟎𝟐𝟓 – and thank you for inspiring us to continuously raise the bar! #CXDay #CXDay2025 #CustomerFirst #WithCustomersAtTheCore #TAPI #CustomerExpereince #Progress   

This month, we held #TAPITechSeptember - a #global internal initiative dedicated to learning, knowledge-sharing, and cross-functional collaboration across our teams. It was more than just an event -it was a reflection of who we are. At #TAPI, we crave science and technology, and that spirit came to life through sessions on Green Chemistry, Continuous Manufacturing, Solid State Science, AI, automation & computational tools, CDMO and many more- delivered in clear, practical terms for all employees, regardless of role. And as a community more than a company, we believe learning is stronger when it’s shared. These two days were a powerful example of how we support one another, grow together, and keep curiosity alive across the globe. We’re proud to invest in our people and to make continuous learning part of how we move forward, together.   #TAPITechSeptember #LivingTheTAPIValues #WeCraveScienceAndTechnology #ACommunityMoreThanACompany #LifeAtTAPI Augusto Canavesi Maytal Piran Damir Sahnic, PhD sanjay rathod Raman Gangwar Syed Aziz Imam Quadri Roberta Volonté Paolo Simone Tiseni Tomislav Biljan Mukesh Singh Ozren Wittine Tomas Holas Daniel Pinchuk Michael Tikhonov Lajos Mészáros Sumeet Kumar sanjay rathod M.Anantha Rajmohan Sathiyamoorthy . A Arina Ceausu Anette Yahav-Levi Ana Bohanek Rodrigo Silva Ozren Wittine Hila Seti Bloch Dr. Amit Singh Devmani Sharma Alexandr Jegorov Tihamér Paál Meenakshi sundaram Itay Liron

Pharma innovation starts with the right partnerships. That’s why TAPI is proud to exhibit at CPHI Worldwide 2025 in Frankfurt. Our teams from Commercial, Procurement, CDMO, Manufacturing, and Product will be there to discuss how we can grow stronger together. Find us at the Frankfurt Messe, Hall 6.1 | Booth A32.

At TAPI, sustainability isn’t a program, it’s our culture. Across our Teva Tech site, we’re embedding greener practices into every step of API manufacturing: ◼️ Energy efficiency – Smarter systems that cut usage by 5–15% per year. ◼️ 100% renewable electricity – Since April 2024 (IREC in progress). ◼️ Zero-liquid discharge mindset – Advanced monitoring, wastewater treatment & solvent recovery. ◼️ Paperless production – Piloting electronic batch records. ◼️ Better waste management – Recycling plastics, metals, batteries & more. The result? Lower GHG emissions, stronger supply reliability, and a greener future for our customers and communities. Read more here: https://lnkd.in/dKHmMMpj

Here at TAPI, we offer 𝐑𝐨𝐦𝐢𝐝𝐞𝐩𝐬𝐢𝐧 𝐀𝐏𝐈 in crystalline form: Methanolate.  ☑️ Years of experience in producing fermented APIs  ➡️ EU-based manufacturing site  ☑️ Extensive expertise and capabilities in the production of highly potent APIs like Romidepsin  ☑️ US DMF available Expand your options with a differentiated offering from TAPI. Talk to our team today: https://bit.ly/46K4C4E 𝘛𝘩𝘦 𝘴𝘢𝘭𝘦 𝘪𝘴 𝘱𝘳𝘰𝘩𝘪𝘣𝘪𝘵𝘦𝘥 𝘦𝘹𝘤𝘦𝘱𝘵 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘱𝘶𝘳𝘱𝘰𝘴𝘦 𝘰𝘧 𝘰𝘣𝘵𝘢𝘪𝘯𝘪𝘯𝘨 𝘮𝘢𝘳𝘬𝘦𝘵𝘪𝘯𝘨 𝘢𝘶𝘵𝘩𝘰𝘳𝘪𝘻𝘢𝘵𝘪𝘰𝘯𝘴, 𝘢𝘯𝘥 𝘪𝘴 𝘰𝘯𝘭𝘺 𝘱𝘦𝘳𝘮𝘪𝘴𝘴𝘪𝘣𝘭𝘦 𝘶𝘯𝘥𝘦𝘳 𝘢𝘯𝘥 𝘪𝘯 𝘢𝘤𝘤𝘰𝘳𝘥𝘢𝘯𝘤𝘦 𝘸𝘪𝘵𝘩 𝘢𝘱𝘱𝘭𝘪𝘤𝘢𝘣𝘭𝘦 𝘭𝘢𝘸.

𝐍𝐄𝐖 𝐔𝐒 𝐃𝐌𝐅 𝐚𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐟𝐨𝐫 𝐒𝐨𝐭𝐨𝐫𝐚𝐬𝐢𝐛 𝐀𝐏𝐈! Advance your oncology pipeline with our high-quality Sotorasib API, now supported by a US DMF available upon request. 𝐎𝐮𝐫 𝐨𝐟𝐟𝐞𝐫 𝐢𝐧𝐜𝐥𝐮𝐝𝐞𝐬: • Proprietary alternative form, protected under TAPI’s IP • Efficient and robust process with strong control of chirality • Differentiated process from the ones described in brand publications GMP material is ready to support your development and regulatory needs. Reach out today to request your copy of the DMF and learn more about our Sotorasib API offering: https://bit.ly/481Tpiq 𝘛𝘩𝘦 𝘴𝘢𝘭𝘦 𝘪𝘴 𝘱𝘳𝘰𝘩𝘪𝘣𝘪𝘵𝘦𝘥 𝘦𝘹𝘤𝘦𝘱𝘵 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘱𝘶𝘳𝘱𝘰𝘴𝘦 𝘰𝘧 𝘰𝘣𝘵𝘢𝘪𝘯𝘪𝘯𝘨 𝘮𝘢𝘳𝘬𝘦𝘵𝘪𝘯𝘨 𝘢𝘶𝘵𝘩𝘰𝘳𝘪𝘻𝘢𝘵𝘪𝘰𝘯𝘴, 𝘢𝘯𝘥 𝘪𝘴 𝘰𝘯𝘭𝘺 𝘱𝘦𝘳𝘮𝘪𝘴𝘴𝘪𝘣𝘭𝘦 𝘶𝘯𝘥𝘦𝘳 𝘢𝘯𝘥 𝘪𝘯 𝘢𝘤𝘤𝘰𝘳𝘥𝘢𝘯𝘤𝘦 𝘸𝘪𝘵𝘩 𝘢𝘱𝘱𝘭𝘪𝘤𝘢𝘣𝘭𝘦 𝘭𝘢𝘸.

Looking for a reliable Linaclotide API?    TAPI delivers a high-performance product, tailored for the unique demands of oral peptide formulations-backed by robust manufacturing, advanced analytics, and deep expertise in cysteine-rich peptides.    ☑️ Tight process control for batch-to-batch reliability  ☑️ Advanced disulfide isomer profiling  ☑️ Exceptional customer partnership   ☑️ US DMF approved and expert RA support    Reach out to learn more about our capabilities: https://bit.ly/3IqVs50 #TAPI #PharmaInnovation #GenericDevelopment #APIDevelopment 𝘛𝘩𝘦 𝘴𝘢𝘭𝘦 𝘪𝘴 𝘱𝘳𝘰𝘩𝘪𝘣𝘪𝘵𝘦𝘥 𝘦𝘹𝘤𝘦𝘱𝘵 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘱𝘶𝘳𝘱𝘰𝘴𝘦 𝘰𝘧 𝘰𝘣𝘵𝘢𝘪𝘯𝘪𝘯𝘨 𝘮𝘢𝘳𝘬𝘦𝘵𝘪𝘯𝘨 𝘢𝘶𝘵𝘩𝘰𝘳𝘪𝘻𝘢𝘵𝘪𝘰𝘯𝘴, 𝘢𝘯𝘥 𝘪𝘴 𝘰𝘯𝘭𝘺 𝘱𝘦𝘳𝘮𝘪𝘴𝘴𝘪𝘣𝘭𝘦 𝘶𝘯𝘥𝘦𝘳 𝘢𝘯𝘥 𝘪𝘯 𝘢𝘤𝘤𝘰𝘳𝘥𝘢𝘯𝘤𝘦 𝘸𝘪𝘵𝘩 𝘢𝘱𝘱𝘭𝘪𝘤𝘢𝘣𝘭𝘦 𝘭𝘢𝘸.